Ceftazidime 250 Mg & Tazobactam 31.25 Mg Injection – Cistaz TZ 281.25

Cistaz-TZ 281.25 — Ceftazidime 250 Mg & Tazobactam 31.25 Mg Injection

Composition: Ceftriaxone 250 gm + Tazobactum 31.25 mg

Cistaz-TZ 281.25 is used for treating mild to moderate bacterial infections. Doctors prescribe it for respiratory tract infections, urinary infections, skin and soft tissue infections, abdominal infections, and certain ENT infections. Tazobactam supports ceftriaxone by blocking resistance, helping the antibiotic work more effectively and clear the infection faster.

Ceftriaxone 250 gm + Tazobactum 31.25 mg — Cistaz-TZ 281.25: Effective Antibiotic for Various Infections

➣ Active Ingredient: Ceftriaxone and tazobactam combine to deliver strong, broad-spectrum antibacterial protection.

➣ Dual Mechanism: Ceftriaxone stops bacterial growth, while tazobactam blocks resistance-producing beta-lactamase enzymes.

➣ Better Tolerability: Formulation ensures smoother treatment experiences with fewer discomforts and improved patient acceptance.

➣ Mode of Action: Combination disrupts bacterial cell wall formation and prevents enzyme-driven drug resistance.

Can be prescribed by: 

➣ General physicians
➣ Pediatricians
➣ Surgeons
➣ Gynecologists
➣ Pulmonologists
➣ Infectious disease specialists

 Disclaimer: To be used under medical supervision only. Not intended for general public promotion. This content is meant for registered healthcare professionals only.